Study of Acupuncture in the Treatment of Hot Flashes in Patients With Hormone Receptor-positive Breast Cancer.

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age30-75
SponsorNanjing University of Traditional Chinese Medicine

About this trial

This study intends to further evaluate the efficacy of acupuncture by comparing the intervention effects of different acupuncture treatment regimens on hot flashes in breast cancer ; and to explore the central effect regulation mechanism of acupuncture intervention on hot flashes based on integrated PET/MRI technology.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Aged 30-75 years old;

Adjuvant hormone therapy (eg, tamoxifen and/or aromatase inhibitors) with or without ovarian function suppression has been administered for at least 4 weeks and is currently on treatment;

Patients with persistent hot flashes for at least 4 weeks and with a frequency of more than 14 hot flashes per week (2 times per day) in the week before inclusion in the study, the weekly average hot flash composite score is 3-4;

Patients after surgery and chemotherapy (if any);

Disqualifiers

Tumor metastases, undergoing chemoradiotherapy or planning surgery;

Pharmacological intervention for hot flashes with hot flash treatment drugs such as selective serotonin reuptake inhibitors (SSRIs) and/or anticonvulsants for at least 4 weeks prior to study initiation;

Patients receiving phytoestrogens, tibolone or analogs, verapril, or specific homeopathic medicines;

Started or changed adjuvant hormone therapy within the past week, or who planned to start or change adjuvant hormone therapy in the past 14 weeks, pregnant or breastfeeding patients;

Trial design

Design model

Parallel

Treatments tested in this trial

  • Acupuncture treatment

    Other intervention

    Acupoint selection: 4 general points + syndrome differentiation acupoints (select or replace 2-4 acupoints according to symptom 1, select 1-2 acupoints according to symptom 2 and symptom 3), and adjust acupoints according to symptoms every week. Frequency: 3 times a week (once every other day) for a total of 8 weeks of continuous treatment. Operation: Use a one-time sterile acupuncture needle (0.30×40mm, Huatuo brand), insert the needle 0.5 inch along the anatomical position, level up and relieve the qi, and keep the needle for 20 minutes.

  • Sham acupuncture treatment

    Other intervention

    Acupoint selection: According to the selected acupoints of the electroacupuncture group, 5-7 positions were selected at the non-meridian and non-acupoint points(points with less nerve distribution, sparseness, and rich muscles). Frequency: 3 times a week (once every other day) for a total of 8 weeks of continuous treatment. Operation: ① Shallow needling scheme: use a disposable sterile acupuncture needle, insert the needle 0.2 inch, without twisting, and keep the needle for 20 minutes. ②Non-invasive acupuncture plan: choose a special comfort needle with no needle tip at the top of the needle, paste a disposable sterile foam pad on the non-acupoint, and use a disposable sterile flat head The acupuncture needles were pierced into the foam pad, lightly touching but not piercing the skin, and not breathing; the needles were kept for 20 minutes.

Treatment groups

90 Participants
are divided into 3 treatment groups
Group A: Treatment group AActive comparator 1 intervention
Group B: Treatment group BSham comparator 1 intervention
Group C: controlNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Change in cancer therapy functional assessment

Cancer therapy functional assessment scores will be assessed with Cancer Therapy Functional Assessment-Breast cancer, version 4.The minimum value is 0 , and the maximum value is 185. The higher scores mean a worse outcome.

Time frame
Baseline, 8, 12,24 weeks later
2

Change in acupuncture efficacy expectation assessment

Acupuncture efficacy expectation assessment scores will be assessed with acupuncture efficacy expectation assessment. The minimum value is 0 , and the maximum value is 20. The higher scores mean a better outcome.

Time frame
Baseline, 8, 12,24 weeks later
3

Change of functional connectivity of whole brain

Functional connectivity will be measured with magnetic resonance imaging based on blood oxygen level dependence.

Time frame
Baseline, 8, 12,24 weeks later
4

Change of metabolism of glucose in the brain

Accumulation of 18F-fluorodeoxyglucose(18F-FDG) will be analyzed by time-related Positron emission tomography.

Time frame
Baseline, 8, 12,24 weeks later

Secondary outcomes

1

Change in sleep

Sleep scores will be assessed with Pittsburgh sleep quality index.The minimum value is 9, and the maximum value is 36. The higher scores mean a worse outcome.

Time frame
Baseline, 8, 12,24 weeks later

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Nanjing University of Traditional Chinese Medicine

Lead sponsor

Xi'an Jiaotong University

Collaborator

Hanzhong Hospital of Traditional Chinese Medicine

Collaborator

Xiang'an Hospital of Xiamen University

Collaborator

Dongzhimen Hospital, Beijing

Collaborator

This trial is not recruiting at the moment. You can still explore other options: